Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-(+)-Cysteine | HCID 5862 | — |
| Reactant | D-1,4-Dithiothreitol | HCID 446094 | — |
| Reactant | HCID 71586737 | HCID 71586737 | — |
| Reactant | HCID 178448371 | HCID 178448371 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | HCID 178448357 | HCID 178448357 | — |
Reaction Steps
The generation of cAC10 ADCs with two and four MMAE molecules per antibody involved a partial reduction followed by reaction with Val-Cit-MMAE. The antibody cAC10 (10 mg/ml) was partially reduced by addition of DTT to a final DTT:mAb molar ratio of 3.0 followed by incubation at 37° C. for ˜2 h. The reduction reaction was then chilled to ˜10° C. and the reduced cAC10 purified away from excess DTT via diafiltration. Following diafiltration, the thiol concentration in the partially-reduced cAC10 was determined by the DTNB (Ellman's) assay; in this manner, an average of about 2 disulfide bonds were reduced, thus exposing about 4 reduced Cys:mAb. To conjugate all of the reduced Cys, Val-Cit-cMMAE was added to a final Val-Cit-MMAE:reduced Cys molar ratio of about 1.15. The conjugation reaction was carried out in the presence of 15% v/v of DMSO and allowed to proceed at about 10° C. for about 30 min. Following the conjugation reaction, excess free Cys (2 moles of Cys per mole of Val-Cit-MMAE) was added to quench unreacted Val-Cit-MMAE to produce the Cys-Val-Cit-MMAE adduct. The Cys quenching reaction was allowed to proceed at about 10° C. for about 30 min. The Cys-quenched reaction mixture was purified and buffer-exchanged into PBS by diafiltration to obtain the partially loaded cAC10-Val-Cit-MMAE.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07837980B2 |
|---|
| Source dataset | uspto-grants-2010_11 |
|---|
| ORD ID | ord-b55b3bdd4d714c49926d2f00cd4f057b |
|---|
| Source note | uspto-grants-2010_11 |
|---|